Mancuso said Altria intends to become a leader in the nicotine pouch category, where it currently trails Philip Morris International's Zyn.
The post Altria CEO Says FDA Delays Create Disadvantage for Law-Abiding Companies first appeared on Tobacco Reporter.
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.